Philip Morris International (PM)
195.49
+2.49 (1.29%)
NYSE· Last Trade: Jul 27th, 12:59 PM EDT
Detailed Quote
| Previous Close | 193.00 |
|---|---|
| Open | 193.00 |
| Bid | 195.44 |
| Ask | 195.52 |
| Day's Range | 192.55 - 196.72 |
| 52 Week Range | 142.11 - 199.78 |
| Volume | 1,295,408 |
| Market Cap | 304.68B |
| PE Ratio (TTM) | 26.89 |
| EPS (TTM) | 7.3 |
| Dividend & Yield | 5.880 (3.01%) |
| 1 Month Average Volume | 5,370,555 |
Chart
About Philip Morris International (PM)
Philip Morris International is a leading global organization in the tobacco industry, primarily known for manufacturing and distributing a variety of smokeable products, including cigarettes and heated tobacco devices. The company is committed to transforming its business by investing in reduced-risk products, promoting alternatives to traditional smoking, such as e-cigarettes and heated tobacco products that aim to deliver nicotine without the harmful effects associated with combustion. With a strong emphasis on innovation and sustainability, Philip Morris International is actively shifting its focus towards a smoke-free future, striving to create a healthier environment while still engaging its customer base. Read More
News & Press Releases
Smart Care Solutions recently announced two major executive leadership appointments to strengthen its corporate structure. The commercial equipment service
Via Talk Markets · July 27, 2026
Philip Morris International Inc.’s (PMI) (NYSE: PM) U.S. businesses (PMI U.S.) today celebrated the opening of its Aurora, Colorado manufacturing campus, a landmark investment representing total capital expenditures of $1.2 billion from 2024-2028. The campus expands the company’s domestic manufacturing capabilities, strengthens supply chain resilience, and positions Aurora as a strategic production and export hub supporting future growth. The site began commercial production in July 2026 and produces ZYN nicotine pouches, joining PMI U.S.’s growing modern nicotine manufacturing network, which includes operations in Owensboro, Kentucky, and Wilson, North Carolina.
By Philip Morris International · Via Business Wire · July 27, 2026
Beverage company Coca-Cola (NYSE:KO) will be reporting earnings this Tuesday before market open. Here’s what investors should know. Coca-Cola beat analysts’ ...
Via StockStory · July 26, 2026
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
Via StockStory · July 24, 2026
Philip Morris International (NYSE:PM) Full-Year Guidance Disappoints Despite Strong Q2 Earnings Beatchartmill.com
Via Chartmill · July 22, 2026
PHILIP MORRIS INTERNATIONAL (NYSE:PM) Presents a High-Quality Technical Breakout Setupchartmill.com
Via Chartmill · July 9, 2026
Philip Morris beat Q2 2026 revenue and EPS estimates on smoke-free growth from IQOS, ZYN and VEEV, though it trimmed full-year EPS guidance and kept revenue growth targets intact.
Via MarketBeat · July 23, 2026
An ETF with double-digit annualized returns and an above-average 2.6% yield? Tell me more.
Via The Motley Fool · July 23, 2026
Philip Morris International (NYSE:PM) reported what management described as a “very strong” second quarter, with growth led by its international smoke-free products business and a better-than-expected performance in combustibles.
Emmanuel Babeau, the company’s group chief financial officer, said Ph
Via MarketBeat · July 22, 2026
Philip Morris beats Q2 2026 Wall Street estimates on strong smoke-free sales, sending PM stock higher. Get key earnings breakdown.
Via Benzinga · July 22, 2026
Philip Morris Intl (NYSE:PM) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to our
Via Benzinga · July 22, 2026
Tobacco company Philip Morris International (NYSE:PM) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 10.4% year on year to $11.19 billio...
Via StockStory · July 22, 2026
Regulatory News:
By Philip Morris International · Via Business Wire · July 22, 2026
Philip Morris will release its Q2 earnings report on July 22. Analysts expect earnings of $2.05/share and revenue of $10.64 billion.
Via Benzinga · July 21, 2026
Tobacco company Philip Morris International (NYSE:PM) will be reporting results this Wednesday before market open. Here’s what to look for. Philip Morris bea...
Via StockStory · July 20, 2026
IYK delivered 8.3% returns over one year with a 2.5% dividend yield, while maintaining broader sector diversification across household products and tobacco alongside food and beverage stocks.
Via The Motley Fool · July 18, 2026
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Via StockStory · July 17, 2026
Regulatory News:
By Philip Morris International · Via Business Wire · July 15, 2026
These high-yield stocks have long track records of dividend consistency and growth.
Via The Motley Fool · July 12, 2026
Consumer staples are considered safe havens in turbulent markets due to their inelastic demand profiles. The flip side is that they frequently fall behind gr...
Via StockStory · July 10, 2026
The tobacco giant is still a resilient income investment.
Via The Motley Fool · July 9, 2026
Domestic cash machine vs. global growth play, one trades at half the valuation multiple.
Via The Motley Fool · July 6, 2026
Anchor your portfolio with this high-yield Dividend King.
Via The Motley Fool · July 1, 2026
FDA authorizes Philip Morris' unit to market 20 ZYN nicotine pouches with reduced disease risk claims after scientific review.
Via Benzinga · July 1, 2026
Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.”
By Philip Morris International · Via Business Wire · June 30, 2026